Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

NCT05974150 · tracked via the Priya Life Science USA tracker

Sponsor

Carevive Systems, Inc.

Phase

Observational

Started

2023-07-19

Last updated

2026-02-23

Condition(s) studied

Breast CancerLung CancerMultiple MyelomaOvarian CancerAcute Myelogenous Leukemia

Investigational drug(s) / intervention(s)

Web based survey

Web based survey: online weekly survey

Study summary

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment.

Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * All participants must be 18 years of age or older. * Subjects may be any stage and anywhere in the treatment continuum. * Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma. * Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer. * All participants must be able to understand English. Exclusion Criteria: * Any patient who cannot understand written or spoken English. * Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer. * Any patient on a treatment clinical trial. * Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

Primary outcome measure(s)

Create Data Set — 1 year
The goal of this registry is to create a data set from real world clinical and patient reported data collected using an electronic care planning system (CPS) that is used in routine care for cancer patients on active treatment

Trial sites (7)

Facility	City	Region	Status
Yale Cancer Center	New Haven	Connecticut	Completed
Northshore University Health System	Evanston	Illinois	Recruiting
Univeristy of North Carolina at Chapel Hill	Chapel Hill	North Carolina	Completed
Duke	Durham	North Carolina	Completed
Cleveland Clinic Mercy Hospital	Canton	Ohio	Recruiting
University Hospitals Seidman Cancer Center	Cleveland	Ohio	Recruiting
Tri-County Hematology & Oncology Associates, Inc.	Massillon	Ohio	Recruiting

More Carevive Systems, Inc. trials in the USA

Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring Active, not recruiting

Other trials for the same condition

AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma Recruiting

A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors Active, not recruiting

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer Active, not recruiting

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) Active, not recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05974150 on ClinicalTrials.gov ↗ ← All trials in the USA